Clinical trial
Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons
NCT00451074 · Nationwide Children's Hospital, Other · Completed
Key facts
| NCT number | NCT00451074 |
|---|---|
| Title | Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons |
| Official title | A Six Month Randomized, Clinical Trial of Gentamicin in Duchenne Muscular Dystrophy Subjects With Stop Codon Mutations |
| Lead sponsor | Nationwide Children's Hospital, Other |
| Collaborators | National Institutes of Health (NIH) NIH National Institute of Neurological Disorders and Stroke (NINDS) |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Duchenne Muscular Dystrophy |
| Intervention type | Drug |
| Interventions | Gentamicin infusions twice a week for six months |
| Enrollment | 12 |
| Start date | Mar 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Mar 23, 2007 |
| Last update posted | Mar 23, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: